Spectral posts investor presentation after FDA De Novo clearance
Spectral AI said its investor presentation highlights FDA De Novo clearance, BARDA funding and near-term commercial launch plans.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.